This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Friday's Small-Cap Winners & Losers

Small-cap stocks traded mostly in the green Friday in concert with the major indices, and Robbins & Myers (RBN) figured prominently among the winners.

The Ohio-based company -- which makes systems for the pharmaceutical, energy and industrial markets -- swung to a profit of $13.2 million, or 77 cents a share, handily topping Wall Street estimates for 59 cents a share, as per Thomson Financial. Last year the company had a penny-a-share loss.

Robbins shares surged 10.8% to $52.92 in support of both the Russell 2000 and the S&P SmallCap 600, which were higher by 0.2% and 0.3%, respectively.

Also propping up both trackers was Ohio-based plastic-resins purveyor A. Schulman (SHLM - Get Report), which jumped 9.8% to $24.66 after posting a profit of 37 cents a share, or 27.6% higher than last year, for the quarter ended May 31. The Street had estimated 25 cents a share.

On the other hand, MMC Energy (MMCE) plummeted 23.8% in unusually heavy trading after the New York-based firm priced a 9.1-million-share offering at $5.50 apiece -- a 19.1% discount to Thursday's closing price. Underwriters have an option for another 1.4 million shares to cover any overallotments; proceeds will go to energy-efficiency upgrades at a couple of its facilities, among other things. Shares were off $1.62 to $5.18.

Pharmaceutical company EpiCept (EPCT), of Tarrytown, N.Y., slid 13.5% to $2.11 after agreeing to sell stock and warrants to institutional investors for gross proceeds of $10 million. EpiCept priced 5.1 million newly minted shares at $1.95 each, and 2.56 million warrants each have an exercise price of $2.93.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
RBN $59.99 0.02%
DSWL $1.42 -4.33%
SHLM $34.72 -1.03%
AAPL $118.03 0.00%
FB $105.79 0.36%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs